Olanzapine enhances adipogenesis and suppresses lipolysis in 3T3‑L1 adipocytes under low‑glucose and weak differentiation/maturation conditions

Olanzapine, a second-generation antipsychotic used in the treatment of schizophrenia, is classified as a multi-acting receptor-targeted antipsychotic. Abnormal weight gain is one of the most common side effects of this drug, along with an increased appetite and food intake. However, weight gain has...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuo, Taisuke, Omori, Yuzuki, Tomita, Takashi, Sadzuka, Yasuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475343/
https://www.ncbi.nlm.nih.gov/pubmed/36168413
http://dx.doi.org/10.3892/etm.2022.11584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475343/
https://www.ncbi.nlm.nih.gov/pubmed/36168413
http://dx.doi.org/10.3892/etm.2022.11584

Ejemplares similares